Comparison of three different in vitro methods of detecting synergy: Time-kill, checkerboard, and E test

被引:547
作者
White, RL
Burgess, DS
Manduru, M
Bosso, JA
机构
关键词
D O I
10.1128/AAC.40.8.1914
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An in vitro method of detecting synergy which is simple to perform, accurate, and reproducible and has the potential for clinical extrapolation is desirable. Time-kill and checkerboard methods are the most widely used techniques to assess synergy but are time-consuming and labor-intensive. The Epsilometer test (E test), a less technically demanding test, has not been well studied for synergy testing, We performed synergy testing of Escherichia coli ATCC 35218, Enterobacter cloacae ATCC 23355, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213 with various combinations of cefepime or ceftazidime with tobramycin or ciprofloxacin using time-kill, checkerboard, and E test techniques. Time-kill testing was performed against each organism alone and in combinations at one-fourth times the MIC (1/4x MIG) and 2x MIG. With checkerboard tests, the same combinations were studied at concentrations ranging from 1/32x to 4x MIG. Standard definitions for synergy, indifference, and antagonism were utilized. E test strips were crossed at a 90 degrees angle so that the scales met at the MIC of each drug alone, and the fractional inhibitory concentration index was calculated on the basis of the resultant zone of inhibition, All antimicrobial combinations demonstrated some degree of synergy against the test organisms, and antagonism was infrequent, Agreement with time-kill testing ranged from 44 to 88% and 63 to 75% by the checkerboard and E test synergy methods, respectively, Despite each of these methods utilizing different conditions and endpoints, there was frequent agreement among the methods, Further comparisons of the E test synergy technique with the checkerboard and time-kill methods are warranted.
引用
收藏
页码:1914 / 1918
页数:5
相关论文
共 31 条
[1]   ANTIMICROBIAL SYNERGISM IN THERAPY OF GRAM-NEGATIVE ROD BACTEREMIA [J].
ANDERSON, ET ;
YOUNG, LS ;
HEWITT, WL .
CHEMOTHERAPY, 1978, 24 (01) :45-54
[2]   DISPARITY BETWEEN TIMED-KILL AND CHECKERBOARD METHODS FOR DETERMINATION OF INVITRO BACTERICIDAL INTERACTIONS OF VANCOMYCIN PLUS RIFAMPIN VERSUS METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
BAYER, AS ;
MORRISON, JO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :220-223
[3]   SYNERGY ASSESSMENT WITH GROWTH-CURVES [J].
BERENBAUM, MC .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (02) :304-304
[4]  
BERENBAUM MC, 1981, J INFECT DIS, V143, P757, DOI 10.1093/infdis/143.5.757-a
[5]   CORRELATIONS BETWEEN METHODS FOR MEASUREMENT OF SYNERGY [J].
BERENBAUM, MC .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (03) :476-478
[6]  
BOLMSTROM A, 1995, 19 INT C CHEM PULS G, pC318
[7]   CORRELATION OF ANTIBIOTIC SYNERGY INVITRO AND INVIVO - USE OF AN ANIMAL-MODEL OF NEUTROPENIC GRAM-NEGATIVE SEPSIS [J].
CHADWICK, FG ;
SHULMAN, ST ;
YOGEV, R .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (04) :670-675
[8]   DETERMINATION OF SYNERGY BY 2 METHODS WITH 8 ANTIMICROBIAL COMBINATIONS AGAINST TOBRAMYCIN-SUSCEPTIBLE AND TOBRAMYCIN-RESISTANT STRAINS OF PSEUDOMONAS [J].
CHAN, EL ;
ZABRANSKY, RJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 6 (02) :157-164
[9]  
DEJONGH CA, 1986, AM J MED, V80, P96
[10]   EVALUATION OF THE INVITRO ACTIVITY OF BMY-28142, A NEW BROAD-SPECTRUM CEPHALOSPORIN [J].
FUCHS, PC ;
JONES, RN ;
BARRY, AL ;
THORNSBERRY, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) :679-682